Islanders with COPD condition to benefit from pilot scheme
Islanders who live with Chronic Obstructive Pulmonary Disease (COPD) are helping to trial a new pilot scheme which will benefit their health, better manage their long-term condition and be more involved in how their care is planned.
This new scheme is part of the Sustainable Primary Care Strategy, which was launched in December 2015; this scheme began in late 2017 and will run for a trial period of one year.
The pilot scheme, in partnership with the States of Jersey Health and Social Services Department, involves around 100 COPD patients who are either already diagnosed with COPD or who are thought to be at risk from it.
Free basic screening and assessment will be offered to all patients. All patients will be managed by the COPD Care Manager and depending on their severity, this will be alongside their GP or the Respiratory Team based at health and Social Services. The Care Manager will help to coordinate access to services and deliver some interventions.
The Care Manager is a free service funded by HSSD, but GP appointments will be paid for in the normal way. The patients will also be offered a Medicines Use Review, either in one of the Co-op pharmacies or, if considered necessary, at home.
Patients who need additional support will also be quickly advised which services can help them if needed, such as Jersey Talking Therapies, Help2Quit, Pulmonary Rehabilitation or other support services by the Care Manager.
Sara Kynicos from Cooperative Medical said “For a primary care provider to work so closely with patients who have COPD is a great opportunity. We hope that the pilot scheme will allow patients to be empowered to better understand their condition and feel that they can be confident in their self-care, while if they have greater need, services can be better co-ordinated for them. In addition, to have access to a multi-disciplinary team when needed is a great boon, and we hope that the pilot will reduce Emergency Department attendances and hospital admissions for issues related to COPD.”